Maintenance of biologic-free remission with naproxen or no treatment in patients with early, active axial spondyloarthritis: results from a 6-month, randomised, open-label follow-up study, INFAST Part 2

OBJECTIVE: To investigate whether biologic-free remission can be achieved in patients with early, active axial spondyloarthritis (SpA) who were in partial remission after 28 weeks of infliximab (IFX)+naproxen (NPX) or placebo (PBO)+NPX treatment and whether treatment with NPX was superior to no trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Sieper, J, Lenaerts, J, Wollenhaupt, J, Rudwaleit, M, Mazurov, V I, Myasoutova, L, Park, S, Song, Y, Yao, R, Chitkara, D, Vastesaeger, N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2014
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888608/
https://www.ncbi.nlm.nih.gov/pubmed/23740231
http://dx.doi.org/10.1136/annrheumdis-2013-203460

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888608/
https://www.ncbi.nlm.nih.gov/pubmed/23740231
http://dx.doi.org/10.1136/annrheumdis-2013-203460

Ejemplares similares